Last Modified: March 24, 2020
These TwinStrand Terms and Conditions (the “Terms”), together with any applicable Order as defined herein (collectively, the “Agreement”), constitute a binding agreement between TwinStrand Biosciences, Inc. (“TwinStrand”) and Customer (each, a “Party”). Customer accepts and agrees to be bound by these Terms as of the Effective Date by (a) executing an Order that references these Terms, or (b) by using TwinStrand’s Products or Services. These Terms, including and together with any terms included in any related Order(s), constitute the sole and entire agreement of the Parties with respect to the subject matter contained herein, and supersedes all prior and contemporaneous understandings, agreements, representations and warranties, both written and oral, regarding such subject matter. Customer’s terms (including purchase order terms), if any, are inapplicable. The Parties acknowledge and agree that if there is any conflict between the terms and conditions of these Terms and any Order, these Terms will supersede and control, unless TwinStrand expressly agrees in writing that the specified provision in the Order will control over a specified conflicting provision in these Terms.
TwinStrand Biosciences, Inc.
3131 Elliott Ave, Suite 750 • Seattle, WA 98121 • USA
+1 (877) 202-8946
For Research Use Only. Not for use in diagnostic procedures.
©2024 TwinStrand Biosciences, Inc. All rights reserved. All trademarks are the property of TwinStrand Biosciences, Inc. or their respective owners. Legal Notices
Stay up to date
Danielle LeBlanc is a Biologist at Health Canada under the supervision of Dr. Francesco Marchetti. Danielle completed her undergraduate and Masters work at Carleton University in Ottawa. Danielle is currently focusing on the implementation of Duplex Sequencing for in vivo mutagenesis assessment at Health Canada.
In her spare time, she loves to cross-country ski, bake cupcakes and craft cocktails.
Dr. Francesco Marchetti is a Senior Research Scientist at Health Canada and Adjunct Research Professor at Carleton University. He chairs the Germ Cell workgroup of the Health and Environmental Science Institute’s Genetic Toxicology Technical Committee and is a member of the Organisation for the Economic Co-Operation and Development Expert Group on Genotoxicity Testing. Dr. Marchetti has authored over 125 peer-reviewed publications.
He was Editor-In-Chief of Environmental and Molecular Mutagenesis (EMM) during 2012-2016 and serves on the editorial boards of EMM and Mutagenesis. Dr. Marchetti is the current President of the Environmental Mutagenesis and Genomic Society.